TCHP and neoplasm: SMYD2 encodes a mono-methyl-transferase that methylates acceptor lysine residues on histones31, 32 and other proteins like tumor suppressor proteins p53 and pRb relevant to tumor progression and/or undetermined epigenetic events33, 34, 35.